Genmab — November 2015
-
Er rimelig sikker på at patentet på Dara er meget omfattende, specielt da det jo netop er så niche ved at være bindende til et specifikt molekyle i kroppen
, CD38. -
http://www.google.com/patents/EP2580243A1?cl=en - The present
invention relates to antibodies directed to human CD38 and to uses of such antibodies, in particular therapeutic uses. -
Interim analysis på CASTOR studiet https://clinicaltrials.gov/ct2/show/NCT02076009?term=Daratumumab+lenalidomide&rank=2
-
http://finance.yahoo.com/news/agenus-acquire-antibody-manufacturing-capability-210000160.html Jeg er så glad fordi jeg er igen er blevet medejer af et antibody manufactory plant
-
Solsen - er der nyheder omkring interim analysen på castor?
-
Spændende. Mon dog ikke at den slags analyser er reserverede for fda? Kan f.eks. Se at imbruvica 1st Line er indsendt, men har ikke offentliggjort resultater
-
Sydbanks kommentarer til regnskabet på analysesiden: http://www.proinvestor.com/analyser
-
Carnegie opjuster FING med 51%.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind